The Patent Finder

Ophthalmic Drug Delivery

Hyperion Defi, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 6 of these applications claim priority to application 61/400,864, filed Jul 15, 2010. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 9,087,145Ophthalmic Drug Delivery
In force
 · High confidence
Hyperion Defi, Inc.In force
High confidence
US 10,073,949Ophthalmic Drug Delivery
In force
 · Medium confidence
Hyperion Defi, Inc.In force
Medium confidence
US 10,839,960Ophthalmic Drug Delivery
In force
 · Medium confidence
Hyperion Defi, Inc.In force
Medium confidence
US 11,398,306Ophthalmic Drug Delivery
In force
 · Medium confidence
Hyperion Defi, Inc.In force
Medium confidence
US 11,839,487Ophthalmic Drug Delivery
In force
 · Medium confidence
Hyperion Defi, Inc.In force
Medium confidence
US 12,490,932Ophthalmic Drug Delivery
In force
 · Medium confidence
Hyperion Defi, Inc.In force
Medium confidence
Application 14/793,895Ophthalmic Drug Delivery
Abandoned
Abandoned Mar 23, 2017
Hyperion Defi, Inc.AbandonedAbandoned Mar 23, 2017
7 of 7 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
6 of these are in force and held by Hyperion Defi, Inc..
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited